STOCK TITAN

Trust tied to MaxLinear (MXL) director Pardun sells 11,000 shares at $105

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

MAXLINEAR, INC director Thomas E. Pardun reported an insider transaction involving common stock. On May 26, 2026, the Thomas E. Pardun Irrevocable Trust, an entity associated with him, completed an open-market sale of 11,000 common shares at $105 per share.

Following this sale, the trust held 55,252 common shares indirectly, while Pardun also held 12,141 common shares directly. The filing reflects a net reduction of 11,000 shares in his reported holdings, combining both direct and indirect positions disclosed.

Positive

  • None.

Negative

  • None.

Insights

Director-linked trust sold 11,000 MaxLinear shares, but sizable holdings remain.

The filing shows an open-market sale of 11,000 MaxLinear common shares at $105 per share by the Thomas E. Pardun Irrevocable Trust, which is associated with director Thomas E. Pardun. This is categorized as a non-derivative, open-market sale.

After the transaction, reported indirect holdings through the trust total 55,252 shares, and direct holdings total 12,141 shares. With no derivative positions listed and continuing sizable ownership, this looks like a portfolio adjustment rather than a transformative change. Overall impact on the investment case appears limited based on this filing alone.

Insider PARDUN THOMAS E
Role null
Sold 11,000 shs ($1.16M)
Type Security Shares Price Value
Sale Common Stock 11,000 $105.00 $1.16M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 55,252 shares (Indirect, By trust); Common Stock — 12,141 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares sold 11,000 shares Open-market sale of common stock on May 26, 2026
Sale price $105 per share Price for 11,000 common shares sold
Indirect holdings after sale 55,252 shares Common stock held by Thomas E. Pardun Irrevocable Trust
Direct holdings after sale 12,141 shares Common stock held directly by Thomas E. Pardun
Net share change -11,000 shares Net buy/sell shares across reported transactions
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
""direct_or_indirect": "I", "ownership_type": "indirect""
Irrevocable Trust financial
"Shares held by the Thomas E. Pardun Irrevocable Trust"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PARDUN THOMAS E

(Last)(First)(Middle)
C/O MAXLINEAR, INC.
5966 LA PLACE COURT, SUITE 100

(Street)
CARLSBAD CALIFORNIA 92008

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MAXLINEAR, INC [ MXL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/26/2026S11,000D$10555,252IBy trust(1)
Common Stock12,141D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares held by the Thomas E. Pardun Irrevocable Trust (the "Trust"). The shares now reported as being owned by the Trust were transferred from direct ownership on October 28, 2020.
Remarks:
/s/ Connie Kwong, as Attorney-in-Fact05/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MaxLinear (MXL) report for Thomas E. Pardun?

MaxLinear reported that a trust associated with director Thomas E. Pardun executed an open-market sale of 11,000 common shares at $105 per share on May 26, 2026. The filing classifies this as a non-derivative sale transaction.

Who actually sold shares in the latest MaxLinear (MXL) Form 4 filing?

The shares were sold by the Thomas E. Pardun Irrevocable Trust, which holds MaxLinear stock indirectly for director Thomas E. Pardun. The trust, not Pardun personally, carried out the 11,000-share open-market sale reported in the filing.

How many MaxLinear (MXL) shares did the trust sell and at what price?

The Form 4 shows the trust sold 11,000 shares of MaxLinear common stock at a price of $105 per share. This was reported as an open-market or private sale transaction under transaction code “S.”

What are Thomas E. Pardun’s holdings in MaxLinear (MXL) after the sale?

After the reported transaction, indirect holdings through the trust total 55,252 shares of MaxLinear common stock. In addition, direct holdings are 12,141 shares. Together, the filing reflects continued meaningful ownership even after the sale.

Does the MaxLinear (MXL) Form 4 show any derivative securities for Thomas E. Pardun?

No derivative securities are listed for Thomas E. Pardun in this Form 4. The filing only reports common stock positions, including the 11,000-share open-market sale and the resulting direct and indirect common stock holdings.